[AlexanderHanff]

Soooo, I have this little birdie who comes to visit every couple of weeks to give me information regarding Phorm. I can't divulge who it is because I honestly don't know, neither can I provide evidence to support anything I am about to say - it is just hearsay or rumour, although I have no reason to believe it not to be true so here goes.

Apparently, Kent's sister works at either the Times or the Financial Times (my source couldn't remember which one) - I suspect it is the Times as the Financial Times gave a damning review of Phorm in their Investors Chronicle magazine. My source believes this may be the reason for the Phorm publicity stunt in the Times this weekend.

Also, and again this is just information from an anonymous source, a senior member of Phorm's business development team quit a week or so ago as they had had enough with all the controversy. This supports information I received several weeks ago stating that several staff were cheesed off and the only reason they were staying was for the stock options.

As for the trials, they are apparently due to start next week but the date could be pushed back again. I have been told these are technical trials not commercial and a total of four advertising companies will be providing the ads.

Again, I have to stress this is from an unconfirmed source so I am not going to say they are facts, you will have to decide for yourself whether or not to believe them. I will add though that the same source has given me information in the past on Phorm which turned out to be true and undisclosed to the general public.

Alexander Hanff